Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business ...

Demand for those products (both versions of the same compound, tirzepatide) has been so high that prior to October, they were ...

Wall Street analysts who follow Viking and Summit expect further gains in 2025. Quick gains are often lost on Wall Street, ...

Hundreds of vials of black-market weight loss drugs have been seized from a home and two clinics in West Tennessee.

Adults on the obesity medication tirzepatide (Zepbound) lost more weight on average than those on semaglutide (Wegovy) in a ...

The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.

US: Sharing the topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial, Eli Lilly and Company ...

Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...

Eli Lilly and Company (NYSE: LLY) today announced topline results from the SURMOUNT-5 phase 3b open-label randomized clinical ...

Obesity is one of the greatest public health issues facing the NHS and weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other ...